Among 94 young breast cancer survivors with one or more live birth(s) after breast cancer treatment, most (95%, 52 of 55) who had not undergone bilateral mastectomy attempted to breastfeed. Although …
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the FDA approval of perioperative nivolumab based on the Phase…
FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injection
With the close of 2024, we wanted to take stock of the eighth year for Blood Advances, which had another banner year. We continue to…
In this issue of Blood, Brown et al1 present the final comparative analysis of the ALPINE study, comparing zanubrutinib with ibrutinib for patients with re
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
A pooled analysis of 9548 HNC cases and 15,783 controls from the International Head and Neck Cancer Epidemiology consortium was conducted to assess the association…
This randomized clinical trial investigates whether a single oral dose of cannabidiol improves scan-related anxiety in women with advanced breast cancer.
Therapeutic options for PD-1 refractory skin cancer 3 Jan – 6PM BST | 1PM EDT | 10AM PDT Allison Betof Warner, Omid Hamid, Inderjit Mehmi…
Help move hematology forward with a charitable gift or pledge to the ASH Foundation. Your generous support enables the ASH Foundation to do more for…
